Centene (CNC)
NYSE Market Closed
Centene Corporation is a US managed care company built around government-sponsored health insurance programmes. Its core business is administering benefits for Medicaid members on behalf of states, while also serving people through Medicare products, Affordable Care Act marketplace plans, and Medicare Part D prescription drug coverage. This focus gives Centene a central role in healthcare access for lower-income families, people with complex health needs, seniors, and individuals buying subsidised coverage on the exchanges.
The company operates health plans across numerous US states and earns revenue primarily from premiums paid by government agencies and members. Medicaid remains its largest membership category, supported by long-term contracts with state governments that outsource care coordination and claims administration to private insurers. Centene also participates in the individual insurance exchanges, where it offers coverage to consumers who do not receive employer-sponsored insurance, and it maintains a smaller presence in Medicare, including drug plans.
Centene’s model depends on managing medical costs while meeting regulatory requirements and quality standards. It works with provider networks, pharmacies, and care management programmes to coordinate treatment, process claims, and support preventive care. Because its membership is heavily tied to public programmes, the company is sensitive to changes in state and federal healthcare policy, reimbursement rates, eligibility rules, and enrolment trends.
For investors, Centene is distinctive because it is one of the largest pure-play operators in government-backed managed care. Its scale, Medicaid expertise, and exchange footprint give it broad exposure to public healthcare spending, but also leave performance closely linked to regulation, contract renewals, and medical cost trends.
Last updated
- Market Cap
- 32.11B
- P/E
- —
- P/FCF
- 4.52
- P/S
- 0.16
- Enterprise Value
- 27.22B
- Sector
- Financials
- Industry
- Hospital and Medical Service Plans
- Address
- 7700 FORSYTH BLVD., ST LOUIS, MO, 63105
Philip Morris Beats Estimates as Smoke-Free Products Drive Earnings Momentum
CENTENE FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Investors in Centene Corporation (CNC) to Inquire About Their Rights in Class Action Lawsuit Before the September 8th Deadline
Faruqi & Faruqi Reminds Centene Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 8, 2025 - CNC
CNC DEADLINE MONDAY: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Centene Corporation Investors to Secure Counsel Before Important September 8 Deadline in Securities Class Action – CNC
LINE LAWSUIT NOTICE: Lose Money on Lineage, Inc.? Contact BFA Law Prior to September 30 Legal Deadline (NASDAQ:LINE)
CNC LAWSUIT NOTICE: Lose Money on Centene Corporation? Contact BFA Law Prior to September 8 Legal Deadline (NYSE:CNC)
Centene Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 8, 2025 to Discuss Your Rights – CNC
CENTENE ALERT: Bragar Eagel & Squire, P.C. Urges Investors in Centene Corporation (CNC) to Inquire About Their Rights in Class Action Lawsuit Before the September 8th Deadline
CNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Centene Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
CNC FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Centene Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important September 8 Deadline in Securities Class Action – CNC
CENTENE NOTICE: BFA Law Notifies Centene Corporation Investors of the Pending Securities Fraud Class Action – Contact BFA Law if You Lost Money (NYSE:CNC)
CNC DEADLINE ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Centene Corporation Investors to Secure Counsel Before Important September 8 Deadline in Securities Class Action – CNC
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Centene
CNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Centene Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Deadline Alert: Centene Corporation (CNC) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Centene Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. September 8, 2025 Deadline to file Lead Plaintiff Motion
CNC FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Centene Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CNC
CHTR CLASS REMINDER: Suffer Losses on Your Charter Communications, Inc. Investment? Contact BFA Law before the October 14 Court Deadline (NASDAQ:CHTR)
CNC CLASS REMINDER: Suffer Losses on Your Centene Corporation Investment? Contact BFA Law before the September 8 Court Deadline (NYSE:CNC)
LINE CLASS REMINDER: Suffer Losses on Your Lineage, Inc. Investment? Contact BFA Law before the September 30 Court Deadline (NASDAQ:LINE)
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 32.11B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 27.22B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.5
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.16
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 9.47
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.14
- EPS
- -13.05
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0.06%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 4.52
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 4.04
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 7.11B
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -30.07%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -7.94%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.76
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 2.37
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 2.37
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 1.2
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 6.46M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 65.03
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 50.35B | 50.09B | 50.14B | 49.11B | 47B |
| Gross profit | 12.05B | 8.61B | 9.24B | 10.31B | 10.5B |
| Operating income | 2.26B | -1.38B | -6.5B | -87M | 1.92B |
| EBITDA | 2.57B | -534M | 556M | 283M | 2.23B |
| Net income | 1.54B | -1.1B | -6.63B | -253M | 1.31B |
| Basic EPS | 3.13 | -2.24 | -13.5 | -0.51 | 2.64 |
| Diluted EPS | 3.11 | -2.24 | -13.5 | -0.51 | 2.63 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 81.18B | 76.75B | 82.09B | 86.4B | 87.04B |
| Total liabilities | 59.65B | 56.69B | 61.03B | 58.89B | 59.03B |
| Total equity | 21.53B | 20.06B | 21.06B | 27.5B | 28.02B |
| Cash & equivalents | 21.26B | 17.89B | 17.06B | 14.51B | 14.82B |
| Current assets | 42.12B | 37.41B | 41.58B | 37.48B | 38.66B |
| Current liabilities | 17.79B | 14.53B | 17.53B | 13.52B | 13.95B |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 4.37B | 437M | 1.36B | 1.79B | 1.51B |
| Investing cash flow | 89M | 660M | 1.24B | -899M | -529M |
| Financing cash flow | -1.06B | -187M | -10M | -1.17B | -250M |
| Change in cash | 3.39B | 910M | 2.59B | -288M | 731M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — CENTENE CORP | View Filing | |
| form 4 | Form 4 — Carson Michael A | View Filing | |
| form 4 | Form 4 — Carson Michael A | View Filing | |
| form 4 | Form 4 — Carson Michael A | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| form 4 | Form 4 — Carson Michael A | View Filing | |
| form 4 | Form 4 — Carson Michael A | View Filing | |
| form 4 | Form 4 — Carson Michael A | View Filing | |
| edgar index | 3 — CENTENE CORP | View Filing | |
| edgar index | 3 — CENTENE CORP | View Filing | |
| form 3 | Form 3 — Carson Michael A | View Filing | |
| form 3 | Form 3 — Carson Michael A | View Filing | |
| form 3 | Form 3 — Carson Michael A | View Filing | |
| form 3 | Form 3 — Finke Daniel P | View Filing | |
| edgar index | 8-K — CENTENE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| form 4 | Form 4 — BLUME JESSICA L. | View Filing | |
| form 4 | Form 4 — BLUME JESSICA L. | View Filing | |
| form 4 | Form 4 — Burdick Kenneth A | View Filing | |
| form 4 | Form 4 — Burdick Kenneth A | View Filing | |
| form 4 | Form 4 — COUGHLIN CHRISTOPHER J | View Filing | |
| form 4 | Form 4 — COUGHLIN CHRISTOPHER J | View Filing | |
| form 4 | Form 4 — Dallas H James | View Filing | |
| form 4 | Form 4 — Dallas H James | View Filing | |
| form 4 | Form 4 — EPPINGER FREDERICK H | View Filing | |
| form 4 | Form 4 — FORD MONTE E | View Filing | |
| form 4 | Form 4 — Samuels Theodore R. II | View Filing | |
| form 4 | Form 4 — Samuels Theodore R. II | View Filing | |
| form 4 | Form 4 — TANJI KENNETH | View Filing | |
| edgar index | SCHEDULE 13G — CENTENE CORP | View Filing | |
| edgar index | 10-Q — CENTENE CORP | View Filing | |
| edgar index | 8-K — CENTENE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| form 4 | Form 4 — MCNALLY TANYA M | View Filing | |
| edgar index | 3 — CENTENE CORP | View Filing | |
| form 3 | Form 3 — PIENKOS THEODORE J | View Filing | |
| edgar index | SCHEDULE 13G/A — CENTENE CORP | View Filing | |
| edgar index | DEF 14A — CENTENE CORP | View Filing | |
| edgar index | DEFA14A — CENTENE CORP | View Filing | |
| edgar index | 8-K — CENTENE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| edgar index | 4 — CENTENE CORP | View Filing | |
| form 4 | Form 4 — Asher Andrew Lynn | View Filing | |
| form 4 | Form 4 — Asher Andrew Lynn | View Filing | |
| form 4 | Form 4 — CASSO KATIE | View Filing | |
| form 4 | Form 4 — KOSTER CHRISTOPHER | View Filing | |
| form 4 | Form 4 — KOSTER CHRISTOPHER | View Filing | |
| form 4 | Form 4 — KOSTER CHRISTOPHER | View Filing | |
| form 4 | Form 4 — KOSTER CHRISTOPHER | View Filing | |
| form 4 | Form 4 — LONDON SARAH | View Filing | |
| form 4 | Form 4 — LONDON SARAH | View Filing | |
| form 4 | Form 4 — MCNALLY TANYA M | View Filing | |
| form 4 | Form 4 — SMITH SUSAN RAYE | View Filing | |
| edgar index | 8-K — CENTENE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — CENTENE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 10-K — CENTENE CORP | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing |